Sign in
Abstract 2175: Genomic and transcriptional profiling characterizes the molecular basis for response to cediranib and temsirolimus in endometrial cancer cells
Abstract   Peer reviewed

Abstract 2175: Genomic and transcriptional profiling characterizes the molecular basis for response to cediranib and temsirolimus in endometrial cancer cells

Shujie Yang, Gavin Pickett and Kimberly K Leslie
Cancer research (Chicago, Ill.), Vol.70(8 Supplement), pp.2175-2175
04/15/2010
DOI: 10.1158/1538-7445.AM10-2175

View Online

Details

Metrics

4 Record Views